BR9810288A - Teste diagnóstico especìfico para espécie para identificar infecção de um mamìfero, como um humano, com chlamydia pneumoniae, fragmento de ácido nucleico derivado de chlamydia pneumoniae, proteìna derivada de chlamydia pneumoniae, anticorpo monoespecìfico policlonal, kit diagnóstico para o diagnóstico de infecção de um mamìfero, como um humano, com chlamydia pneumoniae, composição para imunizar um mamìfero comoum humano, contra chlamydia pneumoniae, uso de uma proteìna, e, uso de um fragmento de ácido nucleico. - Google Patents

Teste diagnóstico especìfico para espécie para identificar infecção de um mamìfero, como um humano, com chlamydia pneumoniae, fragmento de ácido nucleico derivado de chlamydia pneumoniae, proteìna derivada de chlamydia pneumoniae, anticorpo monoespecìfico policlonal, kit diagnóstico para o diagnóstico de infecção de um mamìfero, como um humano, com chlamydia pneumoniae, composição para imunizar um mamìfero comoum humano, contra chlamydia pneumoniae, uso de uma proteìna, e, uso de um fragmento de ácido nucleico.

Info

Publication number
BR9810288A
BR9810288A BR9810288-5A BR9810288A BR9810288A BR 9810288 A BR9810288 A BR 9810288A BR 9810288 A BR9810288 A BR 9810288A BR 9810288 A BR9810288 A BR 9810288A
Authority
BR
Brazil
Prior art keywords
chlamydia pneumoniae
human
mammal
nucleic acid
protein
Prior art date
Application number
BR9810288-5A
Other languages
English (en)
Portuguese (pt)
Inventor
Svend Birkelund
Gunna Christiansen
Katrine Knudsen
Anna-Sofie Hebsgaard Pedersen
Per Mygind
Original Assignee
Loke Diagnostics Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Loke Diagnostics Aps filed Critical Loke Diagnostics Aps
Publication of BR9810288A publication Critical patent/BR9810288A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/125—Gram-negative bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
BR9810288-5A 1997-06-23 1998-06-19 Teste diagnóstico especìfico para espécie para identificar infecção de um mamìfero, como um humano, com chlamydia pneumoniae, fragmento de ácido nucleico derivado de chlamydia pneumoniae, proteìna derivada de chlamydia pneumoniae, anticorpo monoespecìfico policlonal, kit diagnóstico para o diagnóstico de infecção de um mamìfero, como um humano, com chlamydia pneumoniae, composição para imunizar um mamìfero comoum humano, contra chlamydia pneumoniae, uso de uma proteìna, e, uso de um fragmento de ácido nucleico. BR9810288A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK74497 1997-06-23
PCT/DK1998/000266 WO1998058953A2 (en) 1997-06-23 1998-06-19 Surface exposed proteins from chlamydia pneumoniae

Publications (1)

Publication Number Publication Date
BR9810288A true BR9810288A (pt) 2000-09-19

Family

ID=8097044

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9810288-5A BR9810288A (pt) 1997-06-23 1998-06-19 Teste diagnóstico especìfico para espécie para identificar infecção de um mamìfero, como um humano, com chlamydia pneumoniae, fragmento de ácido nucleico derivado de chlamydia pneumoniae, proteìna derivada de chlamydia pneumoniae, anticorpo monoespecìfico policlonal, kit diagnóstico para o diagnóstico de infecção de um mamìfero, como um humano, com chlamydia pneumoniae, composição para imunizar um mamìfero comoum humano, contra chlamydia pneumoniae, uso de uma proteìna, e, uso de um fragmento de ácido nucleico.

Country Status (13)

Country Link
US (2) US7264941B1 (cg-RX-API-DMAC10.html)
EP (1) EP1007685B1 (cg-RX-API-DMAC10.html)
JP (1) JP4160640B2 (cg-RX-API-DMAC10.html)
CN (1) CN1249233C (cg-RX-API-DMAC10.html)
AT (1) ATE323164T1 (cg-RX-API-DMAC10.html)
AU (1) AU749382B2 (cg-RX-API-DMAC10.html)
BR (1) BR9810288A (cg-RX-API-DMAC10.html)
CA (1) CA2294651A1 (cg-RX-API-DMAC10.html)
DE (1) DE69834194T2 (cg-RX-API-DMAC10.html)
DK (1) DK1007685T3 (cg-RX-API-DMAC10.html)
ES (1) ES2264810T3 (cg-RX-API-DMAC10.html)
PT (1) PT1007685E (cg-RX-API-DMAC10.html)
WO (1) WO1998058953A2 (cg-RX-API-DMAC10.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6710033B1 (en) 1996-08-14 2004-03-23 Vanderbilt University Methods and treatment of multiple sclerosis
US6890526B2 (en) 1997-05-06 2005-05-10 Vanderbilt University Methods and reagents for the treatment of multiple sclerosis
US6649370B1 (en) * 1998-10-28 2003-11-18 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
EP1129202A2 (en) * 1998-10-28 2001-09-05 Aventis Pasteur Limited Chlamydia antigenes and corresponding dna fragments and uses thereof
US6872814B2 (en) * 1998-10-29 2005-03-29 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
NZ512308A (en) * 1998-12-01 2004-01-30 Aventis Pasteur Chlamydia antigens and corresponding DNA fragments and uses thereof
AU3790900A (en) 1998-12-01 2000-06-19 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
EP2172214A3 (en) 1999-03-12 2011-03-16 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
WO2000066739A2 (en) * 1999-05-03 2000-11-09 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
CA2385325C (en) * 1999-09-20 2012-04-10 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
US20010048927A1 (en) 2000-02-01 2001-12-06 Richard Stephens Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia
ATE440861T1 (de) * 2000-07-03 2009-09-15 Novartis Vaccines & Diagnostic Immunisierung gegen chlamydia pneumoniae
US7105171B2 (en) 2002-03-07 2006-09-12 The Regents Of The University Of California Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia
EP3452197A4 (en) 2016-05-04 2020-01-22 Children's Hospital & Research Center at Oakland FAST EXTRACTION OF NUCLEIC ACIDS FROM CLINICAL SAMPLES FOR DOWNSTREAM APPLICATIONS
US20220221456A1 (en) * 2019-05-06 2022-07-14 Arocell Ab Respiratory infection detection and classification

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU692889B2 (en) * 1994-08-03 1998-06-18 Hitachi Chemical Company, Ltd. Monoclonal antibodies having a reactivity specific to Chlamydia pneumoniae, method for production of the monoclonal antibodies, such antibody producing cells, method for production of the cells, method for detection and/or measurement of Chlamydia pneumoniae, reagents for the method, method and agents for diagnosis of chlamydia pneumoniae infection
CN100365017C (zh) 1994-09-20 2008-01-30 日立化成工业株式会社 肺炎衣原体抗原多肽
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof

Also Published As

Publication number Publication date
ATE323164T1 (de) 2006-04-15
US20080226679A1 (en) 2008-09-18
JP2002510970A (ja) 2002-04-09
EP1007685A2 (en) 2000-06-14
ES2264810T3 (es) 2007-01-16
WO1998058953A2 (en) 1998-12-30
AU749382B2 (en) 2002-06-27
PT1007685E (pt) 2006-08-31
AU8011998A (en) 1999-01-04
DK1007685T3 (da) 2006-08-14
WO1998058953A3 (en) 1999-03-18
US7264941B1 (en) 2007-09-04
DE69834194D1 (de) 2006-05-24
CN1249233C (zh) 2006-04-05
DE69834194T2 (de) 2007-03-29
CN1261403A (zh) 2000-07-26
EP1007685B1 (en) 2006-04-12
JP4160640B2 (ja) 2008-10-01
CA2294651A1 (en) 1998-12-30

Similar Documents

Publication Publication Date Title
RU2339646C2 (ru) Гибридная и тандемная экспрессия белков нейссерий
AR003124A1 (es) Proteinas estreptococicas de shock termico miembros de la familia de hsp7270,secuencia de adn que codifica para dichos polipeptidos, vector deexpresion, molecula de adn recombinante, metodo para producir un polipeptido o fragmento del mismo, anticuerpo o fragmento del mismo y anticuerpo monoclonal,
Liu et al. Isolation of human salivary mucin MG2 by a novel method and characterization of its interactions with oral bacteria
UA27788C2 (uk) Композиція, що містить виділений фактор лелістада, вакцинна композиція для вакцинації тварин (варіанти), діагностичний набір для виявлення антитіла
BR0112602A (pt) Compostos e métodos para tratamento e diagnóstico de infecção clamidial
EA200000860A1 (ru) Выделенный полинуклеотид (варианты), полинуклеотид (варианты), вектор (варианты), клетка-хозяин (варианты), выделенный полипептид (варианты), способ его получения (варианты), вакцинная композиция (варианты), способ терапевтического или профилактического лечения стрептококковой бактериальной инфекции у животного (варианты), применение (варианты)
CN1322127C (zh) 来自脑膜炎奈瑟氏球菌的basb029多核苷酸和多肽
BRPI0114510B8 (pt) multímero de polipeptídeo monomérico purificado, composição de vacina para profilaxia ou tratamento da infecção por vírus da hepatite e em mamíferos, kit de diagnóstico para infecção por vírus da hepatite e em amostras biológicas, método de diagnóstico in vitro da infecção por vírus da hepatite e em mamíferos, método para detecção in vitro de anticorpos totais contra o vírus da hepatite e em amostras biológicas, método para detecção in vitro do anticorpo igg contra o vírus da hepatite e em amostras biológicas e método para detectar in vitro o anticorpo igm contra o vírus da hepatite e em amostras biológicas
RU2006134631A (ru) Иммуногенные композиции против chlamidia pneumoniae
US12239696B2 (en) Chimeric vaccine antigens for anaplasmosis
KR930702942A (ko) 재조합 고양이 코로나바이러스 에스 단백질
CN100386430C (zh) 用于犬和人埃利希病的免疫诊断的p153和p156抗原及其用途
CN117603366B (zh) 一种布鲁氏菌特异性融合抗原及其应用
Guarino et al. Indirect ELISA for the diagnosis of brucellosis in water buffaloes (Bubalus bubalis) in Italy
DK1007685T3 (da) Overfladeeksponerede proteiner fra chlamydia pneumoniae
JPH06508513A (ja) マイコバクテリウムタンパク質およびその使用
KR100366482B1 (ko) 백신으로서 정제된 분류가능하지 않은 헤모필루스 인프루엔자 p5단백질, 및 그의 정제방법
BRPI0413857A (pt) seqüência de ácido nucleico, fragmento de dna, molécula de dna recombinante, veìculo recombinante vivo, célula hispedeira, proteìna de lawsonia intracellularis, uso de uma proteìna de lawsonia intracellularis, vacina para combater infecções por lawsonia intracellularis, método para a preparação de uma vacina, e, teste diagnóstico
JP2001517091A (ja) Helicobacter pyloriについての抗原性組成物および検出方法
US10022458B2 (en) Animal model protocol, diagnostic, therapeutic and vaccine against digital dermatitis
ES2535543T3 (es) Compuestos de glicano N-enlazado
WO1999042479A1 (en) Novel peptide diagnostic reagent and kit for detection of rickettsiosis
DE60025522T2 (de) Mycoplasma mycoides subsp. mycoides sc antigenisches lppq protein, seine herstellung und verwendung
RU2000131225A (ru) Белки moraxella catarrhalis
MX2010009516A (es) Secuencias novedosas de brachyspira, composiciones inmunogenicas, metodos para la preparacion y usos de las mismas.

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 10 (VIII E IX), 18 (III), 24 E 25 DA LPI.

B15K Others concerning applications: alteration of classification

Free format text: ALTERADA A CLASSIFICACAO DE INT. CL. 6A.: C07K 14/00 PARA INT. CL 2009.01: C12N 15/31, G01N 33/68,C07K 14/295, A61K 39/118, G01N 33/569, C12Q 1/68 E C07K 16/12.

Ipc: C12N 15/31 (2010.01), G01N 33/68 (2010.01), C07K 1

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.